Table 4.
Diagnostic and treatment approaches of CMV lung infection in children.
| Intervention | |
|---|---|
| Bronchoalveolar lavage (BAL), n (%) | 12 (80) |
| CMV PCR (+) in BAL, n (%) | 9/11(82) |
| Neutrophilia in BAL, n (%) | 11/12(92) |
| Lung biopsy, n (%) | 5 (33) |
| Biopsy confirmed CMV, n (%) | 5/5 (100) |
| CMV serum PCR viral load, n (%) | 14/15 (93) |
| CMV PCR viral load (+) in serum | 7/14 (50) |
| CMV copies/μL, median (IQR) | 268 (20–20,000) |
| CMV serology, n (%) | 5/15 (33) |
| CMV IgM (+) in serum | 4/5 (80) |
| CMV treatment, n (%) | 14/15 (93) |
| Ganciclovir, n (%) | 14/14 (100) |
| Valganciclovir, n (%) | 4/14 |
IQR, interquartile range; PCR, polymerase chain reaction.